Abstract:OBJECTIVE To assess risks and costs of hospital admission associated with short term exposure to fine particulate matter with diameter less than 2.5 mu m (PM2.5) for 214 mutually exclusive disease groups. DESIGN Time stratified, case crossover analyses with conditional logistic regressions adjusted for nonlinear confounding effects of meteorological variables. SETTING Medicare inpatient hospital claims in the United States, 2000-12 (n=95 277 169). PARTICIPANTS All Medicare fee-for-service beneficiaries aged 65 or older admitted to hospital. MAIN OUTCOME MEASURES Risk of hospital admission, number of admissions, days in hospital, inpatient and post-acute care costs, and value of statistical life (that is, the economic value used to measure the cost of avoiding a death) due to the lives lost at discharge for 214 disease groups. RESULTS Positive associations between short term exposure to PM2.5 and risk of hospital admission were found for several prevalent but rarely studied diseases, such as septicemia, fluid and electrolyte disorders, and acute and unspecified renal failure. Positive associations were also found between risk of hospital admission and cardiovascular and respiratory diseases, Parkinson's disease, diabetes, phlebitis, thrombophlebitis, and thromboembolism, confirming previously published results. These associations remained consistent when restricted to days with a daily PM2.5 concentration below the WHO air quality guideline for the 24 hour average exposure to PM2.5. For the rarely studied diseases, each 1 mu g/m(3) increase in short term PM2.5 was associated with an annual increase of 2050 hospital admissions (95% confidence interval 1914 to 2187 admissions), 12 216 days in hospital (11 358 to 13 075), US$31m (24m pound, (sic)28m; $29m to $34m) in inpatient and post-acute care costs, and $2.5bn ($2.0bn to $2.9bn) in value of statistical life. For diseases with a previously known association, each 1 mu g/m(3) increase in short term exposure to PM2.5 was associated with an annual increase of 3642 hospital admissions (3434 to 3851), 20 098 days in hospital (18 950 to 21 247), $69m ($65m to $73m) in inpatient and post-acute care costs, and $4.1bn ($3.5bn to $4.7bn) in value of statistical life. CONCLUSIONS New causes and previously identified causes of hospital admission associated with short term exposure to PM2.5 were found. These associations remained even at a daily PM2.5 concentration below the WHO 24 hour guideline. Substantial economic costs were linked to a small increase in short term PM2.5.

Long-term Effect of Air Pollution on Hospital Admissions among Medicare Participants Using a Doubly Robust Additive Hazards Model (DRAHM)

Long-Term Association of Air Pollution and Hospital Admissions Among Medicare Participants Using a Doubly Robust Additive Model

The Long-term Effect of Exposure to Air Pollutants on Mortality among Medicare Participants: A National Study Using an Additive Hazards Model

Long-term Exposure to PM2.5 and Ozone and Hospital Admissions of Medicare Participants in the Southeast USA.

Estimating the Causal Effect of Low Levels of Fine Particulate Matter on Hospitalization.

The effect of long-term exposure to air pollution and seasonal temperature on hospital admissions with cardiovascular and respiratory disease in the United States: A difference-in-differences analysis

Long-term effect of exposure to lower concentrations of air pollution on mortality among US Medicare participants and vulnerable subgroups: a doubly-robust approach

PM2.5 and Hospital Admissions among Medicare Enrollees with Chronic Debilitating Brain Disorders

The Causal Effect of PM2.5 Exposure on Hospital Admissions among Medicare Enrollees with Chronic Debilitating Brain Disorders: A National Study.

Associations Between Long-Term Air Pollution Exposure and the Incidence of Cardiovascular Diseases among American Older Adults.

Long-term Exposure to Air Pollution and Temperature and Hospital Admissions with Cardiovascular Disease in the United States

Long-term Effects of PM2·5 on Neurological Disorders in the American Medicare Population: a Longitudinal Cohort Study.

Cause-Specific Risk and Medical Cost Associated with Acute Exposure to PM2.5 among Older Adults

Long-term Air Pollution Exposure and the Incidence of Cardiovascular Diseases among American Elderly Population

Inverse Probability Weighted Distributed Lag Effects of Short-Term Exposure to PM2.5 and Ozone on CVD Hospitalizations in New England Medicare Participants - Exploring the Causal Effects.

Short Term Exposure to Fine Particulate Matter and Hospital Admission Risks and Costs in the Medicare Population: Time Stratified, Case Crossover Study.

Comparison of Long-Term PM2.5 Concentrations from Ground-Based Monitoring, CMAQ Models and Satellite-Derived AOD to Characterize Adverse Cardiovascular Outcomes

Fine Particulate Matter and Cardiovascular Disease: Comparison of Assessment Methods for Long-Term Exposure.

The impact of long-term PM2.5 exposure on specific causes of death: exposure-response curves and effect modification among 53 million U.S. Medicare beneficiaries

Assessing Short-Term Impacts of PM2.5 Constituents on Cardiorespiratory Hospitalizations: Multi-city Evidence from China.

Ambient Air Pollution Exposure and Adverse Outcomes Among Medicare Beneficiaries With Heart Failure